Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland-Reference-Cited by-同舟云学术

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

Published:2018-02-27 Issue:1 Volume:16 Page:
ISSN:1897-4287
Container-title:Hereditary Cancer in Clinical Practice
language:en
Short-container-title:Hered Cancer Clin Pract

Author:

Kluz Tomasz,Jasiewicz Andrzej,Marczyk Elżbieta,Jach Robert,Jakubowska Anna,Lubiński Jan,Narod Steven A.,Gronwald Jacek

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13053-018-0089-x.pdf

Reference16 articles.

1. Wojciechowska U, Didkowska J, Zatoński W. Cancer. Poland: National Cancer Registy; 2008. http://onkologia.org.pl/wp-content/uploads/Nowotwory2008.pdf

2. Górski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, et al. Founder mutations in the BRCA1 gene in polish families with breast–ovarian cancer. Am J Hum Genet. 2000;66(6):1963–8.

3. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, et al. A high proportion of founder BRCA1 mutations in polish breast and ovarian cancer families. Int J Cancer. 2004;110:683–6.

4. Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, et al. Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in southern Poland. Hered Cancer Clin Pract. 2016;14:5.

5. Gaj P, Kluska A, Nowakowska D, Bałabas A, Piątkowska M, Dabrowska M, et al. High frequency of BRCA1 founder mutations in polish women with nonfamilial breast cancer. Familial Cancer. 2012;11(4):623–8.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods;Pathology and Oncology Research;2024-08-01

2. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

3. The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients;Current Issues in Molecular Biology;2024-05-12

4. Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru;Frontiers in Oncology;2023-08-17

5. Small-scale variants and large deletions in BRCA1/2 genes in Slovak high-grade serous ovarian cancer;Pathology - Research and Practice;2023-06